Tag: Prostate Cancer

Concerted efforts needed to keep prostate cancer in public agenda

Equitable healthcare access and keeping cancer awareness high in the public agenda are among the challenges that remain despite medical advances and technological breakthroughs, say health experts and policy makers who gathered today in Brussels for the seventh Prostate...

EMUC16: National cancer prevention plans need a boost

National cancer plans, which are vital for an effective pan-European cancer care programme, should look closer at prevention, rehabilitation and survivorship issues, according to a public healthcare expert who spoke at the 8th European Multidisciplinary Meeting on Urological Cancers...

EMUC16: Re-thinking active surveillance strategies in PCa

With the emergence of more precise imaging and new results from genomic investigations, onco-urology experts are challenging standard medical strategies and are re-thinking their treatment regimens to achieve better patient care. At the concluding session of the 8th European...

EMUC16: Imaging and the treatment landscape for recurrent PCa

Current and prospective treatment strategies that employ image-guided approaches for prostate cancer recurrences were examined with experts exploring options in radiotherapy, surgery and chemotherapy. Speakers Steven Joniau (BE), Barbara Jereczek-Fossa (IT), George Thalmann (CH) and Cora Sternberg (IT) presented...

EMUC16: Experts tackle combined therapies in prostate cancer

Systemic treatments and optimizing various forms of therapies in high-risk and metastatic forms of prostate cancer were examined at the first-day plenary session of the 8th European Meeting on Urological Cancers (EMUC16) which opened today in Milan, Italy. With...

Indolent cancers: The fine art of sophisticated pathology

Identifying patients with indolent cancers from those with aggressive disease are one of the many challenges faced by many doctors. Thus, the least visible specialist such as a pathologist could actually be holding the crucial key in diagnostic and...

CEM16: Romanian study identifies two SNPs linked to PCa

A Romanian study identified two single nucleotide polymorphisms (SNPs) that were linked to a significant risk for high-grade prostate cancer tumours, according to an award-winning poster presented at the 16th Central European Meeting (CEM16) held over the weekend in...

CEM16: Romania leads best abstracts presentations in Vienna

Romania took the top prizes at the recently concluded 16th Central European Meeting (CEM16) with studies in prostate and renal cancers that impressed jurors with their innovative approaches and fresh perspectives. “The point differences among the top winners were...